Patents by Inventor Fuminari Yamaguchi

Fuminari Yamaguchi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Body weight gain inhibitor
    Patent number: 7582662
    Abstract: The invention provides a pharmaceutical agent containing a compound having an angiotensin II antagonistic activity, a prodrug thereof or a salt thereof, which shows superior effect for the suppression of body weight gain. In addition, the present invention provides such a pharmaceutical agent as does not increase body weights of patients even if a therapeutically effective PPAR? agonistic substance is administered in the treatment of diabetes and other diseases.
    Type: Grant
    Filed: December 25, 2003
    Date of Patent: September 1, 2009
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Zen-ichi Terashita, Keiji Kusumoto, Fuminari Yamaguchi, Yoshimi Imura
  • Body weight gain inhibitor
    Publication number: 20060069133
    Abstract: The invention provides a pharmaceutical agent containing a compound having an angiotensin II antagonistic activity, a prodrug thereof or a salt thereof, which shows superior effect for the suppression of body weight gain. In addition, the present invention provides such a pharmaceutical agent as does not increase body weights of patients even if a therapeutically effective PPAR? agonistic substance is administered in the treatment of diabetes and other diseases.
    Type: Application
    Filed: December 25, 2003
    Publication date: March 30, 2006
    Inventors: Zen-ichi Terashita, Keiji Kusumoto, Fuminari Yamaguchi, Yoshimi Imura
  • Insulin resistance improving agents
    Publication number: 20050032854
    Abstract: The present invention relates to a pharmaceutical agent superior in safety, which shows an excellent effect on insulin resistance improving action and the like for many patients suffering from diseases such as diabetes associated with insulin resistance and the like, and provides an insulin sensitizer, an impaired glucose tolerance improving agent, an agent for the prophylaxis or treatment of diabetes, hyperinsulinemia etc. and the like, which contain 2-ethoxy-1-[[2?-(5-oxo-2,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid or a salt thereof.
    Type: Application
    Filed: December 2, 2002
    Publication date: February 10, 2005
    Inventors: Kiminori Kawahara, Haruto Nakagawa, Hiroki Tamakawa, Keiji Kusumoto, Fuminari Yamaguchi, Zen-ichi Terashita